Exploring the Potential of Cell-Line Engineering

• Are you trying to optimize your cell culture procedures but struggling to keep costs to a minimum?
• Do you need to improve your expression predictability to meet the demand for shorter production times?
• Are you wasting money trying to make the most out of your cell line without knowing all of the facts?

To join the discussion to find solutions to these problems and more, you need to be at the Cell Culture World Congress 2012 taking in place in Munich on the 28^th, 29^th February and 1^st March.

To give you a little taste of the topics up for debate, Day 1 of the congress ends with the following panel discussion;

Evaluating the opportunities to develop cell line engineering

• Given the need to produce biologics faster and cheaper, what strategies are the industry looking to in the future to achieve this?
• Can understanding the benefits and limitations of different cell culture platforms aid in achieving the desired product in the shortest time with maximum yields?
• Evaluating current technologies and methodologies which could deliver an optimized expression systems

Moderator:

Alain Pralong, CEO, Pharma Consulting ENABLE GmbH

Panellists:

Michael Bowen, Protein Sciences & Mammalian Expression Technology, MedImmune LLC

Dr Anne Tolstrup, Head of Cell Culture II, Biopharma, Boehringer Ingelheim

Dr Jolanda Gerritsen, Technology Expert, Cell Line Development, Genmab

Dr Susan Dana Jones, VP & Senior Consultant, Bioprocess Technology Consultants

Hartmut Tintrup, Director Marketing & Business Development, CEVEC Pharmaceuticals